ACI’s FDA Boot Camp and Paragraph IV Disputes Master Symposium

July 6, 2015

The American Conference Institute (“ACI”) will hold its 26th FDA Boot Camp conference in Boston, Massachusetts from September 30 to October 1, 2015.  A copy of the conference program can be obtained here.  Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will co-chair the event with Kleinfeld, Kaplan & Becker, LLP’s Scott M. Lassman.  The conference will include presentations from a virtual “who’s who list” of FDA regulatory experts on myriad topics, including the approval process, pre-approval concerns, product labeling, clinical trials, adverse events reporting, and patent and non-patent marketing exclusivity issues.

ACI will also hold its 3rd annual Paragraph IV Disputes Master Symposium in Chicago, Illinois from September 30 to October 1, 2015, with a post-conference workshop on October 2nd.  A copy of the conference program can be obtained here.  The conference features presentations from preeminent patent litigators representing brand-name and generic drug manufacturers, leading in-house counsel, and esteemed jurists and government representatives who will discuss, analyze, and interpret the latest controversies affecting Paragraph IV litigation.  Hyman, Phelps & McNamara, P.C.’s James C. Shehan will be speaking at the conference. 

FDA Law Blog is a media partner for both conferences.  As such, we can offer FDA Law Blog readers a special $200 discount off the current price tier.  The discount code is: FDA200.  We look forward to seeing you at the conferences.

Categories: Hatch-Waxman |  Miscellaneous